Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Illumina Inc. closed $13.90 short of its 52-week high ($144.02), which the company achieved on January 31st.

On Thursday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $132.27 which represents a slight increase of $6.12 or 4.85% from the prior close of $126.15. The stock opened at $128.04 ...

Leerink Partners analyst Puneet Souda reiterated a Buy rating on Quanterix (QTRX – Research Report) today. The company’s shares ...

The stock's rise snapped a four-day losing streak.

The Rome Study demonstrated the value of extensive sequencing and discussion of individual cancer cases to offer tailored therapeutic choices.

Investors have poured billions of dollars into the "liquid biopsy" space for the early detection and tracking of cancer. Now ...

As the Distinguished William S. C. Chang Endowed Chair in the UC San Diego Jacobs School of Engineering’s Department of ...

Illumina Inc (ILMN) stock saw a decline, ending the day at $128.82 which represents a decrease of $-1.28 or -0.98% from the prior close of $130.1. The stock opened at $130.49 and touched a low of $128 ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

With the recent wrapping up of the World Cancer Congress 2024 in Geneva, Switzerland, and the European Society for Medical ...

The biotech sector is booming, fueled by rising healthcare demands, exciting advancements in technology, and increased FDA ...